T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer

Clinical trial NCT04351230 · WITHDRAWN

Trial details

NCT number: NCT04351230
Sponsor: Academic and Community Cancer Research United
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 HER2 Positive Breast Carcinoma Metastatic Breast Carcinoma Prognostic Stage IV Breast Cancer AJCC v8

Start date: 2020-11-11
Primary completion: 2022-02-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.